Bede Pharmaceuticals (688073.SH) released its performance for the first three quarters, with a net income of 83.85 million yuan, a year-on-year decrease of 26.05%.

Zhitong Finance · Oct 23 17:23

Boide Pharmaceuticals (688073.SH) disclosed the third quarter report of 2024, during the reporting period, the company achieved revenue of 8.1...

Zhītōng Finance APP News, Boide Pharmaceuticals (688073.SH) disclosed the third quarter report of 2024, during the reporting period, the company achieved revenue of 0.811 billion yuan, a year-on-year increase of 0.79%; net profit attributable to the parent company was 83.85 million yuan, a year-on-year decrease of 26.05%; non-recurring net income was 72.39 million yuan, a year-on-year decrease of 40.18%; basic earnings per share was 0.94 yuan.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

毕得医药(688073.SH)发布前三季度业绩，净利润8385万元，同比下降26.05%

Bede Pharmaceuticals (688073.SH) released its performance for the first three quarters, with a net income of 83.85 million yuan, a year-on-year decrease of 26.05%.

Risk Disclaimer

Statement